T T RESULTS: The initial search yielded 246 articles. Twelve RCTs were ultimately selected. The methodological quality scores ranged from 23 to 40 points, with a mean of 34 points (scale range, 0-48; best possible score, 48). The findings of 3 studies that compared dry needling to sham or placebo treatment provided evidence that dry needling can immediately decrease pain in patients with upper-quarter MPS, with an overall effect favoring dry needling. The findings of 2 studies that compared dry needling to sham or placebo treatment provided evidence that dry needling can decrease pain after 4 weeks in patients with upperquarter MPS, although a wide confidence interval for the overall effect limits the impact of the effect. Findings of studies that compared dry needling to other treatments were highly heterogeneous, most likely due to variance in the comparison treatments. There was evidence from 2 studies that lidocaine injection may be more effective in reducing pain than dry needling at 4 weeks.
nomena. 8, 19, 36, 41 MTrPs can contribute to impaired range of motion and increased sensitivity to stretch. 13, 16, 18, 33, 36, 42 Active MTrPs can cause spontaneous pain, whereas latent MTrPs elicit symptoms when compressed. 13, 16, 18, 20, 33, 36, 42 Palpating an MTrP or inserting a needle into an MTrP may elicit a localized twitch response, defined as a brisk contraction of muscle fibers in or around the MTrP. 13, 16, 18, 33, 36, 42 Localized twitch responses are more easily elicited when sensitive loci within an MTrP are identified and targeted. [16] [17] [18] [19] 
Dry Needling
Trigger-point dry needling is a procedure in which an acupuncture-like needle is inserted into the skin and muscle in the location of an MTrP. 11 Needles are removed once the trigger point is inactivated. Dry needling is typically followed by stretching exercises. 14 The actual mechanism of effect of dry needling is still being debated. The localized twitch response that often occurs may interrupt motor end-plate noise, eliciting an analgesic effect. 10 Eliciting a localized twitch response and stretching exercises relax the actin-myosin bonds in the tight bands. 4 Some studies have suggested that pain relief and range-of-motion restoration are greater when a localized twitch response is elicited during dry needling. 16, 18, 19 It has been suggested that the gate control theory of pain may play a role. 14 Dry needling causes stimulation of alpha-delta nerve fibers, thus activating the enkephalinergic inhibitory dorsal horn interneurons and causing opioid-mediated pain suppression. 2 Dry needling may correct levels of several chemicals in the affected muscles, including bradykinin, calcitonin gene-related peptide, and substance P. 10 Needling of MTrPs is also theorized to disrupt reverberatory central nervous system circuits. 30 A previously published systematic review of 7 studies of acupuncture/dry needling for the management of MTrPs in various body regions (including the upper quarter, low back, and lower extremity) found limited evidence in 1 study that dry needling had an overall effect compared to standardized care. 41 Metaanalysis of 4 studies comparing dry needling to a sham (placebo) treatment did not show statistical significance between interventions but noted that, overall, the results suggested a positive treatment effect of dry needling for MTrP pain.
The purpose of this systematic review and meta-analysis was to determine the immediate and longer-term effectiveness in pain reduction of dry needling, specifically in patients with upper-quarter MPS, and to make a recommendation for clinical practice based on the best available evidence.
METHODS
T he studies included in this systematic review and meta-analysis had human subjects, were randomized controlled trials (had a control or comparison group), had a dry-needling intervention group, included participants with upper-quarter myofascial symptoms, and were in the English language. An electronic search of the term dry needling was performed on the following databases: OvidSP MEDLINE , HealthSTAR, and PubMed. Search results are illustrated in FIGURE 1. After removal of duplicates, articles that were not randomized controlled trials were excluded. Next, articles that did not involve subjects with upper-quarter myofascial pain and articles that did not include dry needling as an intervention group were excluded.
Our initial search produced a systematic review and meta-analysis regarding dry needling and acupuncture in the management of MTrP pain. 41 A hand search of that review produced 2 articles that met our inclusion criteria that were not previously identified with our electronic search. All other key references, 1, 4, 9, 15, 17, [20] [21] [22] [23] 26, 43 as well as 1 other systematic review 8 on the topic, were hand searched but did not yield any additional articles. One article 39 published online (ahead of print) in November 2012 was added to the review.
Retained articles were scored independently for internal validity using the evaluation guidelines for rating the quality of an intervention study (the Mac- Dermid Quality Checklist). 28 This tool assesses 7 domains of internal validity (study question, study design, subjects, intervention, outcome, analysis, and recommendations) and has been used in other published reviews. 3, 24 The Mac-Dermid Quality Checklist consists of 24 items, each scored from 0 to 2, with a highest possible score of 48 points. 28 In this review, each article was scored by at least 3 different evaluators. Any differences in scores or ratings were discussed by the reviewers until they reached a consensus score. If the reviewers could not reach a consensus score to within 1 point, an additional reviewer was used to adjudicate the score. If a consensus could still not be reached, the lower score was assigned. In addition, the studies reviewed were assigned a level-of-evidence rating as described by Sackett et al. 34 All authors (except K.M.P.) participated in extraction of relevant data related to MacDermid Quality Checklist scoring. Two of the authors (D.M.K. and K.M.P.) worked as a team to extract relevant data related to meta-analyses. Meta-analyses were performed with MetaAnalyst Version Beta 3.13 (Tufts Medical Center, Boston, MA), with a continuous-variable random-effects model. Four separate meta-analyses were performed, with pain on a visual analog scale (VAS) as the outcome measure: (1) dry needling compared to sham or control, immediate effects; (2) dry needling compared to sham or control at 4 weeks;
(3) dry needling compared to other treatments, immediate effects; and (4) dry needling compared to other treatments at approximately 4 weeks. All studies that compared dry needling to other treatments provided data at 4 weeks, with the exception of the study by DiLorenzo et al, 9 which measured outcomes at 21 days. These data were used in the comparisons at approximately 4 weeks. Outcomes at times other than immediately after and approximately 4 weeks after treatment were not considered in this review, due to variability across studies in other times to outcomes. The VAS pain scores reported by Itoh et al 23 were measured on a 100-point scale (mm), and were converted to a 10-point scale (cm) before entering the data for the meta-analysis.
The data from Chu 4 were not reported such that they could be included in the meta-analysis, thus the study was excluded from meta-analysis. In the meta-analysis of dry needling compared to other treatments (immediate effects), 2 different data sets from the study by Hong 17 were entered separately, because the data were not reported such that they could be combined. In a meta-analysis, Kamanli et al 26 and Itoh et al 23 both assessed the effects of dry needling in comparison to 2 different treatments at 4 weeks. The data for each of these other treatments were entered separately; therefore, these 2 studies are each represented twice in the meta-analysis of dry needling compared to other treatments at approximately 4 weeks.
We used 2 points on a 0-to-10 VAS as a conservative cutoff value for clinical meaningfulness of change in pain for between-group comparisons. Various studies have reported a range of minimal clinically important difference values for numeric or visual analog pain scales for patients with upper-quarter pathologies, including 1 point for patients with chronic musculoskeletal pain, 35 1.3 points for neck pain, 5 1.7 points for chronic pain, 12 2.17 points for shoulder pain, 31 and 3.0 points for patients with neck/upper extremity/lower extremity pain. 38 
RESULTS

T
welve studies that met our inclusion criteria 1, 4, 9, 15, 17, [20] [21] [22] [23] 26, 39, 43 are listed in chronological order in TABLES 1 through 6. Inclusion and exclusion criteria for participants in the reviewed studies are described in TABLE 1. In all studies, subjects had symptoms attributed to upper-quarter MPS, typically involving the neck or shoulder region. Etiology of pain was not consistent across studies. For example, DiLorenzo et al 9 included subjects with shoulder pain fol-lowing cerebrovascular accident, whereas other studies included chronic neck, shoulder, or trapezius myofascial pain, often of ambiguous origin. 1, 4, 15, 17, [20] [21] [22] [23] 26, 39, 43 Exclusion criteria varied across studies but generally included alternative musculoskeletal diagnoses and contraindications for needling. TABLE 2 presents the participants' age range and duration of symptoms where these data were provided by the authors. In general, participants were adults, and in 4 studies 9,15,20,23 they were primarily adults over 60 years of age. Duration of symptoms varied among studies; participants in 8 of the studies had chronic symptoms ranging from 3 months 23 to 63 months 39 in duration. One study 9 included participants whose shoulder symptoms started following a stroke. The study by Ilbuldu et al 21 included only female participants, whereas all other studies appear to have included individuals of both genders.
Intervention groups (independent variables), outcome measurements (dependent variables), and times to outcomes are summarized in TABLE 3. Six of the studies used a true control (placebo or sham) group. 4, [21] [22] [23] 39, 43 One study used the contralateral side of the participants as the control. 20 Eight studies utilized a variety of comparison groups (groups that received interventions other than dry needling to MTrPs). Comparison groups included lidocaine injection, 1, 17, 26 botulinum toxin injection, 26 laser, 21 nonlocalized acupuncture, 22, 23 and standard rehabilitation (external support, positioning, exercise) for hemiparetic shoulder pain. 9 The comparison group in the study by Ga et al 15 received a treatment (intramuscular stimulation) that, technically, is a dryneedling technique, with subtle differences in technique between the authors' operational definitions of dry needling and intramuscular stimulation. Times to outcomes ranged from immediate 4, 17, 20, 22, 43 to 6 months, 21 with 4 studies 17, 20, 22, 43 reporting only immediate effects. 3 Levels of evidence 34 ranged from 2b 4 to 1b. 1, 9, 15, 17, [20] [21] [22] [23] 26, 39, 43 Internal validity scores (MacDermid Quality Checklist) ranged from 23 4 to 40, 39 with a mean of 34. The articles with the strongest in-ternal validity, as evidenced by relatively higher scores on the MacDermid Quality Checklist, were those by Tekin et al, 39 Ga et al, 15 and Irnich et al. 22 The studies with the weakest internal validity were those [ research report ] by Hsieh et al, 20 Chu, 4 and Hong. 17 As indicated in TABLE 4, all studies reported significant decreases in pain in the groups receiving dry needling. In many cases, comparison groups also realized an improvement in pain.
Meta-analysis: Dry Needling Compared to Sham or Control, Immediate Effects
Four studies compared dry needling to sham or control and assessed immediate effects on pain (FIGURE 3). 20, 22, 39, 43 The overall effect size (standardized mean difference) of 1.06 (95% confidence interval [CI]: 0.05, 2.06) suggests a large effect 7 favoring dry needling over sham or control. Heterogeneity was high (I 2 = 86.3%). Three of the 4 studies entered into this meta-analysis favored dry needling.
The study with the largest treatment effect 20 used the same subject's uninvolved side as the control, and reported a raw between-group effect size of 4.0 VAS points, which is clinically meaningful. The other 2 studies that favored dry needling 39, 43 had large treatment effects (0.88 and 0.75, respectively), but their raw between-group effect sizes (1.4 and 1.2 VAS points, respectively) were of questionable clinical meaningfulness. 
Meta-analysis: Dry Needling Compared to Sham or Control at 4 Weeks
Three studies compared the effects of dry needling to sham or control on pain at 4 weeks (FIGURE 4). 21 39 had the highest internal validity score of any study in this review.
Meta-analysis: Dry Needling Compared to Other Treatments, Immediate Effects
Two studies compared dry needling to other treatments and assessed immediate effects on pain (FIGURE 5). 17 
Meta-analysis: Dry Needling Compared to Other Treatments at Approximately 4 Weeks
Six studies compared the effects of dry needling to other forms of treatment on pain at 4 weeks (FIGURE 6). 1, 9, 15, 21, 23, 26 Two of the studies included 2 other treatment groups, and the results from each of these treatments were entered separately into the meta-analysis, such that 8 data sets were entered. 28 Level-of-evidence ratings were assigned as described by Sackett et al. 34 Study Key Findings Quality/Level of Evidence* Hong 17 • Decreased pain immediately and at 2 wk in both groups (when an LTR was elicited), and immediately in lidocaine injection group even if no LTR was elicited (P<.05). Between groups, greater decrease in pain in lidocaine injection group at 2 wk (P<.05) • Improved pressure pain threshold immediately and at 2 wk in both groups (when an LTR was elicited) (P<.05) • Improved CS ROM immediately and at 2 wk in lidocaine injection group (when an LTR was elicited) and in DN showed a wide 95% CI that crossed the line of no difference. The raw betweengroup effect size at 4 weeks was 1.66 VAS points (favoring laser), which approaches clinical meaningfulness. Ga et al 15 found no difference between dry needling and intramuscular stimulation. However, intramuscular stimulation is very similar to dry needling, and therefore the lack of difference was expected.
Publication Bias
Funnel plots (FIGURE 2) were created to determine the risk of publication bias for the 4 separate meta-analyses. The funnel plots for dry needling compared to sham or control for both immediate effects and at 4 weeks, as well as the funnel plot for the immediate effects of dry needling compared to other treatments, were asymmetrical, demonstrating a risk for publication bias. The funnel plot for dry needling compared to other treatments at 4 weeks was symmetrical, demonstrating a lower likelihood for publication bias.
DISCUSSION
I nterpretation of the collective body of results of the studies reviewed is complicated due to the variance in comparison groups, control conditions, dosage of intervention, outcomes, outcome measurement tools, times to outcomes, and internal validity (quality) of the studies. The studies that have been published to date were conducive to the 4 meta-analyses described, but the high heterogeneity for all analyses performed requires special consideration.
Dry Needling Compared to Sham or Control, Immediate Effects
In studies that compared dry needling to sham or control, high heterogeneity of pooled results (I 2 = 86.3%) was likely attributable to the small number of studies, variance across studies in the conditions for the sham or control group, and differences in inclusion criteria. Hsieh et al 20 However, such results should be interpreted with caution, as raw between-group differences in pain scores in 2 of these studies were of questionable clinical meaningfulness. 39, 43 The data by Chu 4 were not included in the meta-analysis because they could not be extracted in a way conducive to inclusion in the meta-analysis. Chu 4 reported a greater percentage of subjects with pain relief for the dry-needling group compared to the control group (P<.0001). However, the internal validity of that study was the weakest of the 12 studies reviewed, with a score of 23 points on the MacDermid Quality Checklist. Additional high-quality randomized controlled trials are needed to further elucidate the immediate effects on pain of dry needling compared to a sham or placebo.
Dry Needling Compared to Sham or Control at 4 Weeks
At 4 weeks, 2 studies 23,39 provided evidence of a strong effect of dry needling compared to a sham or control, with clinically meaningful raw between-group effect sizes. Although the overall effect was strong, it was confounded by a wide 95% CI due to the equivocal findings of the study by Ilbuldu et al. 21 It was unclear if the examiners in the Ilbuldu et al 21 study were blinded, and a low number of subjects (n = 40) without a priori power analysis might have contributed to the finding of a lack of difference between groups (type II error). The high heterogeneity for this meta-analysis (84.2%) may, in part, be explained by the small number of stud- 
Dry Needling Compared to Other Treatments, Immediate Effects
Based on 2 studies, 17,22 dry needling is not superior to lidocaine injection or nonlocal acupuncture to decrease pain immediately after treatment. One study 17 provided evidence that a lidocaine injection had a greater effect on pain, approaching clinical meaningfulness, when the treatments did not induce a localized twitch response. When a localized twitch response was associated with the treatments, the difference between lidocaine injection and dry needling was neither significant nor clinically meaningful. This finding supports the theory that a localized twitch response is an important component of effective dry needling. The high heterogeneity (90%) in this metaanalysis is partly explained by the small number of studies and the variety in comparison treatments: Hong 17 used lidocaine injection and Irnich et al 22 used nonlocal acupuncture. In addition, there were some differences in the subject inclusion criteria between these studies.
Dry Needling Compared to Other Treatments at Approximately 4 Weeks
Based on 6 studies, dry needling is not superior, in general, to the other treatments studied to reduce pain at 4 weeks. However, the overall small 7 effect (-0.07, favoring other treatment) must be viewed with caution because of the high heterogeneity (95%) attributable to the variety of other treatments, dosages of dry needling, and diagnoses of the subjects. Two studies 1, 26 provided evidence that a lidocaine injection or botulinum toxin injection had a greater effect than dry needling on reducing pain, with raw be- tween-group effect sizes that were clinically meaningful. When dry needling was compared to standard rehabilitation in subjects with shoulder pain following a cerebrovascular accident, 9 dry needling was favored (with a strong effect) over rehabilitation, with a raw betweengroup effect size that approached clinical meaningfulness. In another study of patients with neck pain, 23 21 subjects in all groups performed stretching exercises. In these studies, it is possible that the stretching exercises contributed to the treatment effects. [ research report ] techniques emphasize the potential importance of a localized twitch response during treatment. Often, the definition of MPS includes the phenomenon of a localized twitch response in response to stimulation of an MTrP. Of the 12 studies we reviewed, 8 clearly described whether a localized twitch response was desired or elicited upon dry needling of a subject's MTrP. 1, 15, 17, 20, 22, 23, 39, 43 In general, provocation of a localized twitch response was described as a necessary component of the dry-needling technique. In a study comparing dry needling with lidocaine injection, Hong 17 noted that a lack of localized twitch response in either group was associated with little change in pain, tenderness, or range of motion. Ga et al 15 compared dry needling with intramuscular stimulation, a variation of dry needling that involves "grasping and winding up" of the muscle (by the needle) and a "stronger stimulation" response. Localized twitch response rates were not different between the groups, with nearly all participants demonstrating localized twitch responses during treatment. Both groups had decreased pain and improved pain pressure threshold at 4 weeks. Further research is needed to clarify whether a localized twitch response is a valid predictor of success or a necessary component of dry-needling treatment in patients with upper-quarter MPS. However, it does appear that provocation of a localized twitch response is common with the dry-needling technique.
Importance of the Localized Twitch Response in Dry Needling
Limitations
The limitations of this review include the use of only 1 search term (dry needling). However, based on the hand search of references from 2 other systematic reviews, 8, 41 it is unlikely that any relevant articles were overlooked. Our methods did not permit us to calculate concordance statistics for data extraction. The authors recognize the value of this information in retrospect but cannot adjust for this aspect of the methodology.
Other tools, such as the PEDro scale, 29 are available to rate the internal valid-ity of randomized controlled trials. The MacDermid Quality Checklist 28 afforded us the opportunity to closely analyze the design and methods of the studies; however, the reliability of the MacDermid Quality Checklist has not been well described in the literature, which may be a limitation. The interpretation of study findings was based on meta-analysis results and consideration of raw difference in pain scores between groups. Any potential instability of the MacDermid Quality Checklist, in terms of reliability, did not have an effect on our conclusions or recommendations. Of great concern was the high heterogeneity in each of the 4 meta-analyses we performed. In general, such high heterogeneity may bring into question whether it is even appropriate to perform a meta-analysis. However, our discussion of likely reasons for this high heterogeneity and our consideration of findings of individual studies provide a rationale to pursue the meta-analyses.
Another limitation of this review is the evidence of publication bias in the asymmetrical funnel plots (FIGURE 2) for dry needling compared to sham or control for both immediate effects and at 4 weeks, as well as dry needling compared to other treatments for immediate effects. Publication bias may result from a lower publication rate of negative results, exclusion of publications in foreign languages, or an inability to access work not submitted for publication. 6 The authors did not attempt to locate unpublished research or research in foreign languages examining the impact of dry needling on patients with upper-quarter MPS. However, funnel-plot asymmetry can be influenced by the heterogeneity of studies included in a meta-analysis 40 and can be challenging to interpret when the number of studies included is small. 6 Thus, the asymmetrical funnel plots in this study cannot be interpreted conclusively due to the small number of studies included (range, [3] [4] as well as the heterogeneity of those studies (range, 84.2%-90%).
Because most studies of longer-term effects described outcomes at approxi-mately 4 weeks, we chose that time point for meta-analysis. However, 2 studies reported outcomes up to 12 weeks. 1, 23 Ay et al 1 found no between-group differences at 12 weeks, whereas Itoh et al 23 reported less pain in the dry needling group at 12 weeks. Although further study of the long-term effects of dry needling is needed, we feel that the time points addressed in this review (immediate and 4 weeks) are of great value, as the goal of dry needling is rapid relief of pain so that patients can be progressed to other forms of therapy, such as exercise and postural correction. Several studies in this review reported statistical superiority of dry needling compared to sham or other outcomes, including pain pressure threshold, 17,43 range of motion, 17, 22, 43 self-reported disability, 23 and number of tender MTrPs. 4 A limitation of this systematic review was that it did not provide analyses of these secondary variables.
All studies reviewed had methodological limitations, which were extensive in some cases. Key methodological limitations of the studies are summarized in TABLE 6. Only 1 study 22 provided a cursory interpretation of pain reduction from the perspective of minimal clinically important difference. The parameters of dry-needling treatment technique varied across studies. The studies by Chu 4 and Ga et al 15 referred to intramuscular stimulation as a consideration in dry needling, with Ga et al 15 actually using intramuscular stimulation as a comparison group. Times to outcomes varied across studies, with 4 reporting only immediate effects. 17, 20, 22, 43 The immediate effects on pain are of interest, but longer-term effects on a comprehensive group of functional and clinically relevant measures should be considered when designing future studies. In general, future studies should be carefully designed to avoid many of the methodological limitations found in the studies published to date.
The external validity of several of the studies is limited due to the age ranges and gender bias of the sample. Four studies 9,15,20,23 focused on an older sample, while Ilbuldu et al's 21 sample of 18-to 50-year-old adults was composed of female subjects only. Furthermore, there was variance in the causes or diagnoses explaining the upper-quarter myofascial pain in the studies reviewed (as described under the inclusion criteria in TABLE 1). For example, the findings of DiLorenzo et al 9 are relevant only for patients with shoulder pain who have suffered a recent stroke.
CONCLUSION B
ased on the studies published to date, we recommend (grade A) 34 dry needling, compared to sham or placebo treatment, for immediate reduction of pain in patients with upperquarter MPS, based on the results of 3 individual randomized controlled trials 20, 39, 43 included in the meta-analysis of 4 studies and on the overall effect size derived from that meta-analysis. We cautiously recommend (grade A) 34 dry needling, compared to sham or placebo treatment, for reduction of pain at 4 weeks in patients with upper-quarter MPS, based on results of 2 individual randomized controlled trials 23, 39 included in a meta-analysis of 3 studies. However, it must be noted that the overall effect of the 3 studies combined is ambiguous due to a large CI of the otherwise strong effect size. Future studies should be critically reviewed to inform the evolution of these recommendations. Additional research with high-quality study design and appropriate choices of comparative treatments will aid in developing more conclusive evidence for dry needling. More evidence is needed to establish efficacy of dry needling compared to other interventions for upper-quarter MPS. However, it appears that injection with lidocaine may be superior to dry needling for pain reduction both immediately after treatment and at 4 weeks. t
KEY POINTS
FINDINGS: A large immediate effect of dry needling compared to sham or placebo to decrease pain in individuals with upper-quarter MPS was found in 3 of the 4 studies, with raw between-group effect sizes ranging from 1.2 to 4.9 points on a pain VAS. At 4 weeks, a large effect favoring dry needling was tempered by a large CI, but findings from 2 cohorts showed a large effect favoring dry needling, with clinically meaningful raw between-group effect sizes ranging from 3.1 to 3.6 points on a pain VAS. Several studies have compared dry needling to other treatments, with outcomes varying from no difference to a difference either favoring dry needling or the alternate intervention. IMPLICATIONS: We recommend (grade A) 34 dry needling for immediate reduction of pain in patients with upper-quarter MPS, and cautiously recommend (grade A) 34 dry needling for reduction of pain at 4 weeks in patients with upper-quarter MPS. CAUTION: The limited number of studies performed to date, combined with methodological flaws in many of the studies, prompts caution in interpreting the results of the meta-analyses performed here. Variance in study factors, such as control conditions and comparison treatments, contributed to high heterogeneity in the results of the meta-analyses.
